These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2740184)

  • 1. [Renal diseases and platelet activating factor].
    Pirotzky E; Colliez P; Guilmard C; Braquet P
    Pediatrie; 1989; 44(3):163-7. PubMed ID: 2740184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils.
    Spinnewyn B; Blavet N; Clostre F; Bazan N; Braquet P
    Prostaglandins; 1987 Sep; 34(3):337-49. PubMed ID: 3432553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelet activating factor in kidney transplant rejection in the rat.
    Butterly DW; Spurney RF; Ruiz P; Pirotzky E; Braquet P; Coffman TM
    Kidney Int; 1995 Aug; 48(2):337-43. PubMed ID: 7564100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor in organ transplant rejection.
    Foegh ML; Chambers E; Khirabadi BS; Nakanishi T; Ramwell PW
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():377-82. PubMed ID: 2526501
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of platelet-activating factor-induced acute renal failure by BN 52021.
    Pirotzky E; Colliez P; Guilmard C; Schaeverbeke J; Mencia-Huerta JM; Braquet P
    Br J Exp Pathol; 1988 Apr; 69(2):291-9. PubMed ID: 3377967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N; Agrawal DK; Suliaman FA; Townley RG
    Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor.
    Foegh ML; Khirabadi BS; Rowles JR; Braquet P; Ramwell PW
    Transplantation; 1986 Jul; 42(1):86-8. PubMed ID: 3523888
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.
    Braquet P; Hosford D
    J Ethnopharmacol; 1991 Apr; 32(1-3):135-9. PubMed ID: 1881152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs.
    Koltai M; Lepran I; Szekeres L; Viossat I; Chabrier E; Braquet P
    Eur J Pharmacol; 1986 Oct; 130(1-2):133-6. PubMed ID: 3780855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
    Koltai M; Pirotzky E; Braquet P
    Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection.
    Pignol B; Henane S; Pirotzky E; Mencia-Huerta JM; Braquet P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):259-65. PubMed ID: 3259039
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
    Braquet P; Guinot P; Touvay C
    Agents Actions Suppl; 1987; 21():97-117. PubMed ID: 3314418
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists.
    Mathison R; Davison JS; Befus AD
    Br J Pharmacol; 1992 Jun; 106(2):263-6. PubMed ID: 1393261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage.
    Hirashima Y; Endo S; Otsuji T; Karasawa K; Nojima S; Takaku A
    J Neurosurg; 1993 Apr; 78(4):592-7. PubMed ID: 8450333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
    Fletcher JR; DiSimone AG; Earnest MA
    Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats.
    Kirejczyk JK; Chyczewski L; Debek W
    Rocz Akad Med Bialymst; 1995; 40(1):65-76. PubMed ID: 8528996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.